Professor Scolyer’s Battle Against Glioblastoma: A triumph?
Brain cancer remains one of the most challenging diseases to treat due to its complexity and the blood-brain barrier, which limits the effectiveness of many therapies. Among the various types of brain tumors, glioblastoma (GBM) stands out as particularly aggressive, with a median survival rate of just 12-18 months even after standard treatment. However, in June 2023, when renowned Australian pathologist Professor Richard Scolyer was diagnosed with stage 4 glioblastoma, he approached his diagnosis not only as a patient but also as a scientist determined to fight back using innovative strategies inspired by his expertise in melanoma research.
Read more